Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 1.51K 53.84K 115.28K 234.91K 153.45K 327.73K 630.88K 500.89K 592.43K 409.42K 183.35K 237.24K 397.49K 682K 992.6K 844.22K
Cost of Revenue
n/a n/a n/a n/a -90 1.55M 1.81M 1.88M 1.7M 14.62M 2.76M 5.75M 3.77M 12.82M n/a 3.73M 2.75M
Gross Profit
n/a 1.51K 53.84K 115.28K 235K -1.39M -1.48M -1.24M -1.2M -14.03M -2.36M -5.56M -3.53M -12.42M 682K -2.74M -1.9M
Operating Income
-606.26K -445.63K -622.2K -899.32K -788.09K -2.68M -2.65M -2.55M -2.4M -3.5M -4.17M -7.09M -5.76M -4.28M -3.58M -4.51M -3.15M
Interest Income
n/a n/a 102.00 1.51K 7.57K 13.13K 13.66K 13.35K 23.83K 25.35K 3.6K 204.00 95.00 754.00 1.24K 1.72K 529.15K
Pretax Income
-1.47M -1.19M -1.53M -1.46M -735.18K -2.86M -2.62M -2.68M -2.41M -3.65M -4.11M -7.22M -5.82M -4.42M -3.6M -4.69M -2.64M
Net Income
-1.47M -1.21M -1.53M 12.88M -3.09M -2.86M -2.62M -2.68M -2.41M -3.65M -4.11M -7.22M -5.82M -4.42M -3.6M -4.69M -2.64M
Selling & General & Admin
448.07K 260.57K 337.25K 507.17K 774.94K 1.7M 1.75M 1.95M 1.8M -240.68K 2.39M 1.53M 2.24M 497.58K 1.47M 1.85M 1.32M
Research & Development
32.58K -6.23K 77.85K 184.46K 245.13K 454.31K 833.48K 751.86K 708.78K 5.74M 1.74M 5.75M 3.77M 3.5M 2.86M 3.73M 2.75M
Other Expenses
125.61K 192.8K 260.94K 322.97K n/a n/a n/a n/a 390.13K -1.41M 448.44K -3.09K n/a n/a n/a n/a n/a
Operating Expenses
606.26K 447.13K 676.04K 1.01M 1.02M 2.84M 2.98M 3.18M 2.9M 4.09M 4.58M 7.28M 6M 4.67M 4.26M 5.5M 3.99M
Interest Expense
548.00 1.49K 586.00 864.00 611.00 8.36K 3.5K 3.83K 609.00 7.77K 6.38K 12.33K 22.41K 9.34K 9.99K 22.94K 20.74K
Selling & Marketing Expenses
n/a n/a n/a n/a 203.2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
606.26K 447.13K 676.04K 1.01M 1.02M 2.84M 2.98M 3.18M 2.9M 4.09M 4.58M 7.28M 6M 4.67M 4.26M 5.5M 3.99M
Income Tax Expense
n/a n/a n/a n/a n/a 8.36K 3.5K 3.83K 58.02K n/a n/a 205.00 95.00 9.34K 9.99K 22.94K n/a
Shares Outstanding (Basic)
819.54K 815.2K 812.79K 812.79K 812.79K 793.64K 643.99K 601.57K 510.41K 497.46K 398.21K 312.23K 315.79K 289.81K 284.35K 283.83K 279.33K
Shares Outstanding (Diluted)
819.54K 815.2K 812.79K 812.79K 812.79K 793.64K 643.99K 601.57K 510.41K 497.46K 398.21K 312.23K 315.79K 289.81K 284.35K 283.83K 279.33K
EPS (Basic)
-1.2 -1.03 -1.88 15.60 -3.8 -3.6 -4.07 -4.45 -4.72 -7.34 -10.32 -22.8 -18 -15.6 -13.2 -16.8 -9.44
EPS (Diluted)
-1.2 -1.48 -1.88 15.60 -3.8 -3.6 -4.07 -4.45 -4.72 -7.34 -10.32 -22.8 -18 -15.6 -13.2 -16.8 -9.44
EBITDA
-1.47M -1.16M -1.47M -1.34M -785.15K -2.77M -2.56M -2.6M -364.72K -3.57M -4.09M -7.13M -5.71M -4.33M -3.5M -4.58M -2.53M
EBIT
-1.47M -1.19M -1.53M -1.46M -734.57K -2.85M -2.61M -2.67M -369.4K -3.64M -4.1M -7.21M -5.8M -4.41M -3.59M -4.67M -2.62M
Depreciation & Amortization
2.12K 23.8K 53.58K 112.38K 2.94K 79.39K 75.38K 75.41K 75.78K 75.65K 77.32K 83.35K 86.83K 82.97K 87.74K 88.26K 88.64K